BNF:

2.3.2

Status:

Amber

Decision Date:

November 2017

Comments

See shared care guideline for the maintenance of sinus rhythm after successful cardioversion.  (Decision date - November 2017).

 Be aware of MHRA warnings

Amber Drug Classifications

• 2: Requiring short or medium term (e.g. 3-6 months) specialist monitoring of efficacy or until the patient is stable

search again